▶ 調査レポート

世界の臨床意思決定支援システム市場2022年-2027年:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:Clinical Decision Support Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の臨床意思決定支援システム市場2022年-2027年:成長・動向・新型コロナの影響・市場予測 / Clinical Decision Support Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) / MRC2203A204資料のイメージです。• レポートコード:MRC2203A204
• 出版社/出版日:Mordor Intelligence / 2022年1月
• レポート形態:英文、PDF、115ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥703,000 (USD4,750)▷ お問い合わせ
  Site Licence¥962,000 (USD6,500)▷ お問い合わせ
  Corporate License¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社の本市場調査レポートでは、世界の臨床意思決定支援システム市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、型式別(知識ベースCDSS、非知識ベースCDSS)分析、配信方法別(クラウド、オンプレミス)分析、コンポーネント別(ハードウェア、ソフトウェア、サービス)分析、製品別(統合型CDSS、スタンドアロン型CDSS)分析、地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の臨床意思決定支援システム市場規模:型式別(知識ベースCDSS、非知識ベースCDSS)
・世界の臨床意思決定支援システム市場規模:配信方法別(クラウド、オンプレミス)
・世界の臨床意思決定支援システム市場規模:コンポーネント別(ハードウェア、ソフトウェア、サービス)
・世界の臨床意思決定支援システム市場規模:製品別(統合型CDSS、スタンドアロン型CDSS)
・世界の臨床意思決定支援システム市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争状況(Cerner Corporation、EPIC、IBM、…)
・市場機会・将来傾向

The clinical decision support systems market was valued at approximately USD 1,450 million in 2020, and it is expected to reach USD 2,490 million by 2026, registering a CAGR of nearly 9.4% during the forecast period, 2021-2026.

Amid the COVID-19 pandemic, the health systems of countries are majorly dependent on online services. Through video calls, patients are getting appointments with doctors, which is helping in treating and monitoring the diseases, thereby propelling the clinical decision support systems market.

According to the World Ageing 2019 report, it was estimated that there were 703 million persons aged 65 years or over in the world in 2019. This group of the population mainly suffers from a lot of chronic diseases and needs regular health checks and treatments for the prevention of diseases. Based on the current situation across the world, there may be a lot of people, such as the elderly population and pregnant women, who may need health checks, but due to the COVID-19 outbreak across the world, the hospitals and clinics are unable to provide services. But several countries are increasingly providing online services, which is boosting the market.

Moreover, the healthcare facilities, such as hospitals, diagnostic centers, and clinics, are showing interest in clinical decision support systems in minimizing medication prescription errors, adverse drug events monitoring, and other medical errors.

The rising demand for reducing healthcare expenditure, need for improvement in the quality of care, and technological advancements in healthcare IT in hospitals are the major factors that are likely to boost the growth of the clinical decision support systems (CDSS) market.

Furthermore, according to the Organization for Economic Co-operation and Development (OECD) survey report, in 2018, the average per capita health expenditure was about USD 7,317 in Switzerland, USD 6,187 in Norway, and USD 5,005 in Australia. Due to high healthcare expenditure across the world, the rising demand to reduce healthcare expenditure has a positive impact on the market.

According to a study report by Elena Bellodi et. al. published in the BMC Medical Informatics and Decision Making 2017, the implementation of a clinical decision support system (CDSS) can have a positive impact on healthcare costs. Furthermore, the experience of using a clinical decision support system (CDSS) can also result in good practice to be implemented by other healthcare organizations as per the study conducted in Italy.

However, lack of trust in the systems, as CDSS are in the initial stages of development, lack of skilled labor, and suggestions from CDSS for unnecessary diagnostic testing hinder the market growth.

Key Market Trends

The Cloud-based Segment is Expected to Hold a Major Market Share

The increasing healthcare expenditure and adoption of cloud computing are the major drivers for the expansion of the cloud-based segment of the market. According to a survey by RightScale, nearly 95% of organizations run cloud-based applications. The hardware of electronic medical record (EMR) systems offered by different vendors is different. Hence, developing a standard CDSS software, which can run on multiple EMR systems, is a major challenge.

Furthermore, local knowledge management of CDSS may require extensive processing power and storage capacity, which can result in high operating costs. In contrast, cloud-based applications are operated in remote servers, and executing them does not require a large amount of computational power or large storage space in the user’s device.

Cloud-based applications do not depend on web browsers, which makes them inherently safer than web-based applications. In a cloud-based clinical decision support system, processing units are hosted on remote servers, which can be located in multiple data centers across the world, making them less vulnerable to cyberattacks. The increasing availability of cloud technology, owing to their benefit, is expected to drive the usage of cloud-based CDSS over the forecast period.

North America is Expected to Hold a Significant Share in the Market in the Forecast Period

The clinical decision support systems (CDSS) market in North America is driven due to the rise in the technological advancement in CDSS, higher awareness rate among patients, and rising investments in healthcare IT solutions in the region are expected to boost the growth of the market during the forecast period.

As per the Centers for Disease Control and Prevention (CDC) 2019, 6 in 10 Americans have at least one chronic disease, like heart disease and stroke, cancer, or diabetes. These chronic diseases are the leading causes of death and disability in the United States, and they are also a leading driver of healthcare costs. Moreover, according to the Organization for Economic Co-operation and Development (OECD) survey report, in 2019, the average per capita health expenditure in the United States was about USD 11,072.

In 2016, the Agency for Healthcare Research and Quality (AHRQ) launched a new initiative to disseminate and implement the findings of patient-centered outcomes research (PCOR) through clinical decision support (CDS). The two major goals of the initiative were to accelerate the movement of evidence into practice through CDS and to make CDS more shareable, standards-based, and publicly available. Such research efforts help engage patients, clinicians, provider organizations, and information technology professionals to improve decision-making in healthcare with the help of CDSS. These initiatives may fuel the growth of the CDSS market over the forecast period in North America.

Competitive Landscape

The clinical decision support systems market has the presence of well-diversified international, regional, and local players. However, some big international players dominate the market owing to their brand image and market reach. The studied market is consolidated and competitive. The market players are continuously focusing on acquisitions, mergers, provision of customized solutions, and expansions in the untapped commercial markets. Moreover, companies are also investing huge amounts in developing new products and platforms, with enhanced and improved features as a part of the commercialization strategy.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Advancement in Healthcare IT in Hospitals
4.2.2 Rising Demand to Reduce Healthcare Expenditure
4.2.3 Need for Improvement in Quality of Care and Reducing Human Errors
4.3 Market Restraints
4.3.1 Privacy and Data Security Concerns Related to Cloud-based CDSS
4.3.2 Lack of Skilled Professionals
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Model
5.1.1 Knowledge-based CDSS
5.1.2 Non-knowledge CDSS
5.2 By Mode of Delivery
5.2.1 Cloud-based
5.2.2 On-premise
5.3 By Component
5.3.1 Hardware
5.3.2 Software
5.3.3 Services
5.4 By Product
5.4.1 Integrated CDSS
5.4.2 Standalone CDSS
5.5 By Application
5.5.1 Medical Diagnosis
5.5.2 Alerts and Reminders
5.5.3 Prescription Decision Support
5.5.4 Information Retrieval
5.5.5 Other Applications
5.6 Geography
5.6.1 North America
5.6.1.1 United States
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.2 Europe
5.6.2.1 Germany
5.6.2.2 United Kingdom
5.6.2.3 France
5.6.2.4 Italy
5.6.2.5 Spain
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 Japan
5.6.3.3 India
5.6.3.4 Australia
5.6.3.5 South Korea
5.6.3.6 Rest of Asia-Pacific
5.6.4 Middle-East and Africa
5.6.4.1 GCC
5.6.4.2 South Africa
5.6.4.3 Rest of Middle-East and Africa
5.6.5 South America
5.6.5.1 Brazil
5.6.5.2 Argentina
5.6.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Cerner Corporation
6.1.2 EPIC
6.1.3 IBM
6.1.4 Change Healthcare
6.1.5 Meditech
6.1.6 Koninklijke Philips NV
6.1.7 Siemens Healthcare
6.1.8 Allscripts Healthcare Solutions Inc.
6.1.9 Wolters Kluwer Health
6.1.10 Mckesson Corporation
6.1.11 Zynx Health
6.1.12 Elsevier BV
6.1.13 NextGen Healthcare Inc.
6.1.14 Agfa-Gevaert Group
6.1.15 Athenahealth Inc.
6.1.16 VisualDx

7 MARKET OPPORTUNITIES AND FUTURE TRENDS